Syngene International Limited (NSE:SYNGENE)
India · Delayed Price · Currency is INR 654.60
-2.15 (-0.33%)
Jan 8, 2026, 9:20 AM IST
Syngene International Employees
Syngene International had 6,533 employees as of March 31, 2025. The number of employees increased by 23 or 0.35% compared to the previous year.
Employees
6,533
Change (1Y)
23
Growth (1Y)
0.35%
Revenue / Employee
5.74M INR
Profits / Employee
716.67K INR
Market Cap
261.45B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 6,533 | 23 | 0.35% |
| Mar 31, 2024 | 6,510 | -337 | -4.92% |
| Mar 31, 2023 | 6,847 | 872 | 14.59% |
| Mar 31, 2022 | 5,975 | 538 | 9.90% |
| Mar 31, 2021 | 5,437 | 491 | 9.93% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Apollo Hospitals Enterprise | 42,497 |
| Cipla | 30,313 |
| Zydus Lifesciences | 27,917 |
| Aurobindo Pharma | 27,707 |
| Mankind Pharma | 26,978 |
| Alkem Laboratories | 18,785 |
| Glenmark Pharmaceuticals | 15,800 |
Syngene International News
- 21 days ago - Syngene International Ltd Webinar on Clinical Trials Market Call Transcript - GuruFocus
- 2 months ago - Syngene International Ltd (BOM:539268) Q2 2026 Earnings Call Highlights: Navigating Growth ... - GuruFocus
- 2 months ago - Q2 2026 Syngene International Ltd Earnings Call Transcript - GuruFocus
- 5 months ago - Goldman Sachs maintains buy on Syngene, bullish on FY26 early-teens growth outlook, sees 15.5% upside on Q1 beat and rising CRO-led margin gains - Business Upturn
- 6 months ago - Syngene Q1 profit up 59% to Rs 87 crore - The Times of India
- 6 months ago - Syngene International Q1 Results: Revenue grows 11% YoY to Rs 790 crore, Net profit jumps 59% YoY - Business Upturn
- 7 months ago - Syngene International receives EIR from USFDA for Biocon Park facility, inspection concludes with VAI classification - Business Upturn
- 9 months ago - Why are Syngene shares down 10% despite Q4 net profit jumping 2.8% YoY? - Business Upturn